Physician profile
Stephen A Flores
NPI 1467779207
$4,300.39
in general payments reported to CMS, 2019-2025
21 companies · $323 in 2025
The $323 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $174 · 2021: $328 · 2022: $1,684 · 2023: $423 · 2024: $242 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rattan and Associates | $1,287.36 | 2022-2025 | |
| Stryker Corporation | $729.87 | 2020-2025 | Mako, Alphavent, Aequalis Perform+ |
| Djo, LLC | $687.03 | 2019 | |
| Zimmer Biomet Holdings, INC. | $503.56 | 2021-2022 | |
| Arthrex, INC. | $219.30 | 2019 | |
| Vericel Corporation | $123.80 | 2023-2025 | Maci |
| Si-Bone, INC. | $121.51 | 2021-2022 | |
| Smith+Nephew, INC. | $117.75 | 2019-2021 | |
| Bioventus LLC | $94.04 | 2022-2024 | Exogen Ultrasound Bone Healing System, Bioness Integrated System (Bits)2.0.5, Durolane |
| Fx Shoulder Solutions, INC | $77.57 | 2019-2021 | |
| Depuy Synthes Sales INC. | $68.94 | 2019-2023 | Monovisc |
| Anika Therapeutics, INC. | $65.10 | 2025 | Integrity Implant, Tactoset, Hyalofast |
| Pacira Therapeutics, INC. | $47.64 | 2019 | |
| Abbott Laboratories | $30.50 | 2024 | Proclaim |
| Horizon Therapeutics Plc | $23.17 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $21.06 | 2025 | Exparel |
| Merck Sharp & Dohme LLC | $18.99 | 2021 | |
| Baudax Bio INC. | $17.65 | 2021 | |
| Orthofix Medical, INC. | $16.54 | 2024 | Physio-Stim |
| Acacia Pharma INC | $14.95 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.